Skip to content

At CTI, we’re dedicated to bringing forward innovative treatments for various diseases – including neurodegenerative conditions like Alzheimer’s and Parkinson’s, addiction and other psychiatric illnesses, rare genetic disorders, and cancer. Our scientists focus on discovering novel therapeutics and repurposing – often improving – existing treatments by exploring modalities such as small molecule drugs, oligonucleotides, and antibodies. 

Experienced researchers and students with various backgrounds are exposed to a range of scientific areas, from basic biomedical science to translational therapeutic projects. Our research relies heavily on the concurrent development of leading-edge approaches in molecular biology, genomics, and epigenetics – how your behaviors and environment can affect how your genes work. The concept of personalized (precision) medicine is at the core of many of our projects.

As part of the CTI research team, our scientists collaborate with colleagues in academic research and those in the pharmaceutical and biotechnology industries. We believe “it takes a village” to succeed in any therapeutic endeavor. This collaboration enhances the exchange of knowledge and expertise – enriching the learning experience.

In the CTI’s relatively short history at the university, several therapeutic projects have progressed from our labs to clinical trials. And many basic science discoveries have helped to develop novel research techniques. These successes further strengthen our resolve to uncover tomorrow’s breakthroughs and bring innovative treatments to those who need them.